MSH|^~\&|ADM|ARH|||202002051544||ADT^A02|4162662|D|2.2|||AL|NE
EVN|A02|202002051544
PID|1|FHATVIG0004326|AB00007409|AB7450|PCSTEST^ABALONE||19850126|M|||600 BLUEBERRY LANE^^SURREY^BC^V3S 4N4|||||||AB000293/18|9876012603
PV1|1|I|AB-1BAKER^AB1B-B111^1|EL|||SEUSST^SEUSS *TEST^THEODORE^*TEST* G^^^^^^^^^XX|||MEDS||||||||IN|||||||||||||||||||||ARH|||||201806211537|
PV2||W^Ward|
OBX|1|ST|1010.1^WEIGHT^CPT4||60.000||||||F
OBX|2|TX|ADM CURRES^Residing at current add. since (DD/MM/YY)^ADM||20010101||||||F
OBX|3|CE|ADM IDSOUR^SOURCE OF ID^ADM||BCCOP^BC CareCard \T\ Other Photo||||||F
OBX|4|CE|ADM MDRO2^Canada in the last 12 months?^ADM||N^NO||||||F
OBX|5|CE|ADM MDRO4^Bangladesh or Vietnam in the last 12 months?^ADM||N^NO||||||F
OBX|6|CE|ADM MRSA2^correctional/shelter in the last 12 months?^ADM||N^NO||||||F
OBX|7|CE|AcADL00000^Mobility prior to admission^ADM||1^Independent||||||F
OBX|8|CE|AcADL00200^Mobility aids used prior to admission^ADM||5^Cane||||||F
OBX|9|CE|AcHEHT0M00^Home environment - housing type^ADM||1^House||||||F
OBX|10|TX|AcHYGCOMM0^Personal care comments^ADM||test6||||||F
OBX|11|CE|AcKATZBA01^KATZ Bathing^ADM||1^Independence (1)||||||F
OBX|12|CE|AcKATZCO00^KATZ continence^ADM||1^Independence (1)||||||F
OBX|13|CE|AcKATZDR00^KATZ dressing^ADM||1^Independence (1)||||||F
OBX|14|CE|AcKATZFE00^KATZ feeding^ADM||1^Independence (1)||||||F
OBX|15|CE|AcKATZTI00^KATZ toileting^ADM||1^Independence (1)||||||F
OBX|16|TX|AcKATZTO00^KATZ total points^ADM||6||||||F
OBX|17|CE|AcKATZTR00^KATZ transferring^ADM||1^Independence (1)||||||F
OBX|18|TX|AcLIVOTH00^Living with others prior to admission^ADM||N||||||F
OBX|19|TX|AcPERBOT00^Peri bottle in use^ADM||Y||||||F
OBX|20|TX|AcPTSHOWE0^Patient showered^ADM||Y||||||F
OBX|21|CE|AcTOASST02^Toileting assistance^ADM||1^Unassisted||||||F
OBX|22|TX|AdBIRTH010^Expected date of delivery^ADM||20180827||||||F
OBX|23|CE|AdBIRTH030^Single/Multiple births^ADM||1^Singleton||||||F
OBX|24|CE|AdDISCHA00^Destination^ADM||4^Assisted living||||||F
OBX|25|CE|AdGENREF00^Geriatric Emergency Nurse referrals^ADM||1^Addiction services||||||F
OBX|26|CE|AdGENRSE00^Geriatric Emergency Nurse report sent to^ADM||1^Assisted living facility||||||F
OBX|27|CE|AdGOUDB000^Geriatric Outreach Nurse discharge barriers^ADM||2^Delay in consult||||||F
OBX|28|TX|AdHHL02301^Medical alert service used at home^ADM||Y||||||F
OBX|29|TX|AdHXCOND00^History of presenting condition^ADM||COPD||||||F
OBX|30|CE|AdINSM0000^Information source^ADM||1^Patient||||||F
OBX|31|TX|AdINTNEE00^Interpreter needed^ADM||Y||||||F
OBX|32|TX|AdMRPNAM00^MRP or physician name^ADM||Dr. Syrup||||||F
OBX|33|CE|AdPTA00300^Equipment used prior to admission^ADM||5^Raised toilet seat (RTS)||||||F
OBX|34|CE|AdPTA00900^Respiratory equipment used prior to admission^ADM||1^Home oxygen||||||F
OBX|35|CE|AdPTA02000^Dressing assistance required prior to admission^ADM||2^Partial assistance||||||F
OBX|36|CE|AdPTA02400^Toileting assistance required prior to admission^ADM||2^Partial assistance||||||F
OBX|37|CE|AdPTA02600^Washing assistance required prior to admission^ADM||2^Partial assistance||||||F
OBX|38|CE|AdPTA03400^Meal prep assistance required prior to admission^ADM||2^Friend||||||F
OBX|39|CE|AdPTA03700^Med management assistance required prior to admission^ADM||1^None||||||F
OBX|40|CE|AdPTA03900^Medication management function prior to admission^ADM||1^Verbal prompting||||||F
OBX|41|CE|AdPTA04000^Medication management method prior to admission^ADM||1^Pill bottle||||||F
OBX|42|CE|AdPTA04300^Shopping assistance required prior to admission^ADM||2^Family||||||F
OBX|43|CE|AdPTA04600^Transportation assist required prior to admission^ADM||1^None - drives self||||||F
OBX|44|CE|AdPTA04900^Financial mgmt assist required prior to admission^ADM||1^None||||||F
OBX|45|CE|AdPTA05200^Assistive devices used prior to admission^ADM||2^Glasses~3^Contacts||||||F
OBX|46|TX|AdPTA05800^History of bowel incontinence^ADM||N||||||F
OBX|47|TX|AdPTA05900^History of urinary incontinence^ADM||N||||||F
OBX|48|CE|AdPTA08800^Community supports utilized prior to admission^ADM||2^Family||||||F
OBX|49|CE|AdPTA09100^Formal supports utilized prior to admission^ADM||2^Lifeline~5^BreatheWELL||||||F
OBX|50|TX|AdPTA12900^Recent falls prior to admission^ADM||N||||||F
OBX|51|CE|CaBL000301^Estimated blood loss^ADM||1^Less than 500 mL||||||F
OBX|52|CE|CaBLDTYP00^Blood group type^ADM||2^A||||||F
OBX|53|TX|CaBTCOMP00^Blood transfusion infusion completed date^ADM||20190308||||||F
OBX|54|TX|CaBTCOTI00^Blood transfusion completed time^ADM||1317||||||F
OBX|55|CE|CaBTCPRD00^Blood transfusion component/product^ADM||1^Red blood cells||||||F
OBX|56|TX|CaBTDATE00^Blood transfusion initiated date^ADM||20190308||||||F
OBX|57|CE|CaBTDEVI00^Blood transfusion infusion device^ADM||1^IV pump||||||F
OBX|58|CE|CaBTFILT00^Blood transfusion filters used^ADM||1^Standard blood filter||||||F
OBX|59|TX|CaBTIMRA00^Blood transfusion intravenous immunoglobulin start rate^ADM||10||||||F
OBX|60|TX|CaBTIVIG00^IVIG type^ADM||Factor 8||||||F
OBX|61|CE|CaBTMETH00^Blood transfusion delivery method^ADM||1^Infusion||||||F
OBX|62|CE|CaBTPPRD00^Blood transfusion plasma component/product^ADM||3^IV immune globulin||||||F
OBX|63|CE|CaBTPREP00^Blood transfusion special preparation^ADM||1^Irradiated||||||F
OBX|64|CE|CaBTRHFA00^Blood transfusion Rh factor^ADM||1^Positive||||||F
OBX|65|TX|CaBTSERI00^Blood transfusion serial number^ADM||123||||||F
OBX|66|TX|CaBTTIME00^Blood transfusion initiated time^ADM||1316||||||F
OBX|67|CE|CaBTTYPE00^Blood transfusion blood type^ADM||2^A||||||F
OBX|68|TX|CaBTVINF00^Intake, Blood transfusion volume infused^ADM||125.00||||||F
OBX|69|TX|CaBTVOLU00^Blood transfusion volume^ADM||300||||||F
OBX|70|TX|CaCADIND01^Cardiac device insertion date^ADM||20190815||||||F
OBX|71|CE|CaCADTYP01^Cardiac device type^ADM||1^Pacemaker||||||F
OBX|72|CE|CaCAPEPA01^Pacemaker mode^ADM||1^AAI||||||F
OBX|73|TX|CaCASHDA01^Cardiac shock event date^ADM||20190815||||||F
OBX|74|TX|CaCASHDC01^Cardiac shock event comments^ADM||testing CSE||||||F
OBX|75|TX|CaCASHTD00^Cardiac shock event time^ADM||1029||||||F
OBX|76|TX|CaCDDCOM00^Cardiac device deactivation comments^ADM||testing||||||F
OBX|77|TX|CaCDDCOM01^Cardiac device deactivation comments^ADM||testing DD||||||F
OBX|78|TX|CaCDDDAT00^Cardiac device deactivation date^ADM||20190813||||||F
OBX|79|TX|CaCDDDAT01^Cardiac device deactivation date^ADM||20190815||||||F
OBX|80|CE|CaCDDMTD00^Cardiac device deactivation method^ADM||1^Magnet||||||F
OBX|81|CE|CaCDDMTD01^Cardiac device deactivation method^ADM||1^Magnet||||||F
OBX|82|CE|CaCDDREA00^Cardiac device deactivation reason^ADM||1^Disable shocks||||||F
OBX|83|CE|CaCDDREA01^Cardiac device deactivation reason^ADM||1^Disable shocks||||||F
OBX|84|TX|CaCDDTIM00^Cardiac device deactivation time^ADM||1132||||||F
OBX|85|TX|CaCDDTIM01^Cardiac device deactivation time^ADM||1030||||||F
OBX|86|TX|CaCDOCDC00^Other cardiac device comments^ADM||testing other comments||||||F
OBX|87|TX|CaCDOCDC01^Other cardiac device comments^ADM||testing CD||||||F
OBX|88|TX|CaCONSEN00^Transfusion consent confirmed^ADM||Y||||||F
OBX|89|TX|CaDRSPRT00^Dressing present^ADM||Y||||||F
OBX|90|TX|CaINFFPA00^Intake, Fresh Frozen Plasma Amount^ADM||358.00||||||F
OBX|91|TX|CaLPRECP00^Loop recorder present^ADM||Y||||||F
OBX|92|TX|CaOVRDPC00^Override pacing comments^ADM||testing pacing comments||||||F
OBX|93|TX|CaOVRDPC01^Override pacing comments^ADM||testing OPC||||||F
OBX|94|TX|CaOVRDPD00^Override pacing date^ADM||20190809||||||F
OBX|95|TX|CaOVRDPD01^Override pacing date^ADM||20190815||||||F
OBX|96|TX|CaOVRDPT00^Override pacing time^ADM||1131||||||F
OBX|97|TX|CaOVRDPT01^Override pacing time^ADM||1029||||||F
OBX|98|TX|CaPLDATE00^PIV Insertion date^ADM||20180820||||||F
OBX|99|TX|CaPLNEED00^Peripheral line daily assessment ongoing need reviewed^ADM||Y||||||F
OBX|100|CE|CaRHFACT00^Rh factor^ADM||1^Positive||||||F
OBX|101|TX|CaTRLESR01^Pacemaker set rate^ADM||80||||||F
OBX|102|TX|CaTRPACA04^Pacemaker capturing appropriately^ADM||Y||||||F
OBX|103|TX|CaTRPASA04^Pacemaker sensing appropriately^ADM||Y||||||F
OBX|104|TX|CmAFU00000^Name of adult responsible for follow-up^ADM||Bob, dad||||||F
OBX|105|TX|CmMRPAWR01^MRP or physician aware^ADM||Y||||||F
OBX|106|CE|CmMRPCME01^MRP or physician communication method^ADM||1^In person||||||F
OBX|107|TX|CmMRPCOC01^MRP or physician communication outcome^ADM||ordered head CT and BW||||||F
OBX|108|TX|CmMRPCTI01^MRP or physician communication time^ADM||0939||||||F
OBX|109|TX|DSPMEDHX^Past Medical History:^ADM||copd, type ii diabetes||||||F
OBX|110|TX|EcGLUCRT00^Glucometer reading time^ADM||1530||||||F
OBX|111|CE|EcPEDHYPO0^Hypoglycemic event intervention^ADM||1^MRP notified~2^Fed||||||F
OBX|112|TX|EnGLYC0000^Glucometer blood glucose^ADM||2.5||||||F
OBX|113|CE|Gi00000100^Hypoglycemia signs and symptoms^ADM||1^None||||||F
OBX|114|CE|Gi00000400^Hyperglycemia signs and symtoms^ADM||1^None||||||F
OBX|115|TX|Gi00000600^Maintaining baseline stool pattern^ADM||N||||||F
OBX|116|CE|Gi00000701^Bowel movement consistency^ADM||1^Soft||||||F
OBX|117|CE|GiABPALP02^Abdominal palpation^ADM||1^Soft||||||F
OBX|118|CE|GiABSHAP00^Abdominal shape^ADM||1^Flat||||||F
OBX|119|CE|GiBM000000^Bowel movement method^ADM||1^Toilet||||||F
OBX|120|CE|GiBM000100^Bowel movement colour^ADM||3^Brown||||||F
OBX|121|TX|GiBM000400^Number bowel movement diapers^ADM||1||||||F
OBX|122|CE|GiBMAMT201^Bowel movement amount^ADM||7^Small||||||F
OBX|123|TX|GiBMINCO00^Bowel movement incontinence^ADM||N||||||F
OBX|124|TX|GiBO000301^Last bowel movement date as reported by patient^ADM||20181210||||||F
OBX|125|TX|GiBO000302^Last bowel movement date as reported by patient^ADM||20180620||||||F
OBX|126|TX|GiBOTTLE01^Intake, Bottle Feeding Amount^ADM||35.0||||||F
OBX|127|CE|GiBSACTI01^Bowel sounds active in all four quadrants^ADM||1^Yes||||||F
OBX|128|TX|GiCONSTI00^Patient experiencing constipation^ADM||N||||||F
OBX|129|TX|GiDIARRH00^Patient experiencing diarrhea^ADM||Y||||||F
OBX|130|TX|GiDUTUPH01^pH duodenal tube^ADM||8.0||||||F
OBX|131|CE|GiETDEDE00^Enteral feeding tube delivery service^ADM||1^Gravity||||||F
OBX|132|CE|GiETSYST00^Enteral feeding tube system^ADM||1^Open||||||F
OBX|133|TX|GiGRESVL01^Gastric residual volume^ADM||8||||||F
OBX|134|TX|GiNAUSVO00^Patient experiencing nausea/vomiting^ADM||N||||||F
OBX|135|TX|GiNICU0010^Duration of breastfeed^ADM||15||||||F
OBX|136|CE|GiNICU0021^Activity during feeding^ADM||2^Skin to skin~3^Held~4^Encourage hand to mouth~7^Tastes of EBM||||||F
OBX|137|TX|GiNICUPH01^pH gastric tube^ADM||7.0||||||F
OBX|138|TX|GiORALNU01^Oral nutrition concerns identified^ADM||N||||||F
OBX|139|TX|GuBDINCO00^Bladder incontinence^ADM||N||||||F
OBX|140|CE|GuBDPAT000^Bladder pattern^ADM||1^Normal||||||F
OBX|141|TX|GuBDSVA000^Bladder scan volume^ADM||250||||||F
OBX|142|CE|GuBDURSS01^Urinary retention signs and symptoms^ADM||7^Change in voiding pattern||||||F
OBX|143|CE|GuBDVM0002^Voiding method^ADM||1^Toilet||||||F
OBX|144|TX|GuDIAP0000^Number urine diapers^ADM||2||||||F
OBX|145|TX|GuUCINS000^Urinary catheter in situ and patent^ADM||Y||||||F
OBX|146|CE|GuUCRFCU00^Reason for urinary catheter continued use^ADM||3^Urine output monitoring||||||F
OBX|147|TX|GuUCSDU000^Urinary catheter securement device in use^ADM||Y||||||F
OBX|148|CE|GuUR000000^Urine amount (estimate)^ADM||3^Moderate||||||F
OBX|149|CE|GuURCLR000^Urine clarity^ADM||1^Clear||||||F
OBX|150|CE|GuURCOL002^Urine colour^ADM||1^Yellow||||||F
OBX|151|CE|GuUROD0000^Urine odour^ADM||1^None||||||F
OBX|152|TX|HxABXMAT02^Antibiotics used in intrapartum period^ADM||Y||||||F
OBX|153|TX|HxANAMAT01^Analgesics used in intrapartum period^ADM||Y||||||F
OBX|154|TX|HxSPTCHX00^Summary of patient's clinical history^ADM||lung cancer - tx with chemo 2018||||||F
OBX|155|TX|HxSSRI0000^Selective serotonin reuptake inhibitor use^ADM||N||||||F
OBX|156|CE|HxSUBUSE01^Substance use^ADM||1^Tobacco||||||F
OBX|157|CE|HxWHX00002^Weight change prior to admission weight history^ADM||2^Unintentional loss||||||F
OBX|158|TX|InABDDCO00^Abdominal dressing intervention comments^ADM||test6||||||F
OBX|159|CE|InABDDIN00^Abdominal dressing intervention^ADM||1^Reinforced||||||F
OBX|160|CE|InABDDR000^Abdominal dressing type^ADM||1^Mepore||||||F
OBX|161|CE|InABDINA00^Abdominal incision appearance^ADM||1^Approximated||||||F
OBX|162|TX|InABDINAOH^Abdominal incision appearance other^ADM||test8||||||F
OBX|163|TX|InABDINC00^Abdominal incision comments^ADM||test11||||||F
OBX|164|CE|InCSOLU000^Abdominal incision cleansing solution^ADM||1^None||||||F
OBX|165|CE|InDRAINA00^Abdominal incision drainage amount^ADM||1^Nil||||||F
OBX|166|CE|InEXDRND00^Abdominal incision drainage description^ADM||1^Serous||||||F
OBX|167|CE|InEXDRSS00^Abdominal incision dressing saturation^ADM||1^None/Scant||||||F
OBX|168|TX|InINDRES00^Dressing dry and intact^ADM||Y||||||F
OBX|169|CE|InISGR0000^infiltration Scale Grade^ADM||1^0||||||F
OBX|170|CE|InPESIDE00^Peripheral line site description^ADM||1^Satisfactory||||||F
OBX|171|CE|InWCREM000^Abdominal incision closure(s) removed^ADM||1^Staples||||||F
OBX|172|TX|InWCREMC00^Abdominal incision closure(s) removed comments^ADM||test10||||||F
OBX|173|TX|InWCREMOH0^Abdominal incision closure(s) removed other^ADM||test9||||||F
OBX|174|CE|InWCTYPE00^Abdominal incision closure type^ADM||1^Staples||||||F
OBX|175|TX|InWCTYPEOH^Abdominal incision closure type other^ADM||test7||||||F
OBX|176|TX|IoNICUIN00^Other intake description^ADM||IV bolus||||||F
OBX|177|TX|IoNICUIN20^Location^ADM||RLE||||||F
OBX|178|TX|IoNICUIN30^Intake, IV Amount^ADM||750.00||||||F
OBX|179|TX|IoNICUIN50^Intake, Free Water Amount^ADM||90.00||||||F
OBX|180|CE|IoSOLUMA00^Solution^ADM||1^NS||||||F
OBX|181|TX|IvCAPCIV00^PIV cap change next due^ADM||20180823||||||F
OBX|182|CE|IvIN000600^Glycemic management sample source^ADM||1^Capillary||||||F
OBX|183|CE|IvIN020200^Insulin route^ADM||1^Subcutaneous||||||F
OBX|184|TX|IvINSERT00^Insertion details^ADM||inserted first attempt||||||F
OBX|185|CE|IvLOCATM01^Location Modifier^ADM||1^Right||||||F
OBX|186|TX|IvNXTDRS00^Next dressing change due^ADM||20180823||||||F
OBX|187|TX|IvPHLEBI00^Phlebitis present^ADM||N||||||F
OBX|188|CE|IvPIVLOC00^Location^ADM||3^Antecubital PIV||||||F
OBX|189|TX|IvPIVNIC00^PIV insertion time^ADM||1359||||||F
OBX|190|CE|IvPL000700^Initial management^ADM||1^Infusion||||||F
OBX|191|TX|IvRATE0000^Rate^ADM||5.00||||||F
OBX|192|TX|IvSIZE0000^Size^ADM||12||||||F
OBX|193|TX|IvTUBCHA00^Next tubing change due^ADM||20180825||||||F
OBX|194|CE|Mh00000100^Speech rate^ADM||3^Normal||||||F
OBX|195|CE|Mh00000300^Elopement: Risk factors^ADM||01^No present concerns||||||F
OBX|196|TX|MhACTIVC00^Current activity^ADM||test2||||||F
OBX|197|CE|MhAD000100^Admission status^ADM||1^Voluntary||||||F
OBX|198|CE|MhAFFECT01^Affect^ADM||2^Flat~7^Blunted||||||F
OBX|199|CE|MhAGGRE011^Aggression/Harm to others: Risk factors^ADM||01^No present concerns||||||F
OBX|200|CE|MhAGGRSK00^Aggression risk^ADM||01^Low||||||F
OBX|201|TX|MhALERTE00^Alert criteria met^ADM||Y||||||F
OBX|202|TX|MhAVBADI00^Date alert initiated^ADM||20180622||||||F
OBX|203|CE|MhAVBALR01^Alert reason^ADM||01^Harm~02^Aggression||||||F
OBX|204|CE|MhAVBALT00^Aggressive violent behaviour identified^ADM||01^History of aggression||||||F
OBX|205|CE|MhAVBSFT00^Safety risks^ADM||01^Agitated||||||F
OBX|206|CE|MhAWOLRK00^Wandering/AWOL risk^ADM||01^Low||||||F
OBX|207|TX|MhBEHIN004^Response to interventions comments^ADM||test||||||F
OBX|208|TX|MhBHATTC01^Attitude other^ADM||test||||||F
OBX|209|TX|MhBHATTI02^Attitude and behaviour comments^ADM||test||||||F
OBX|210|CE|MhBHBEHA00^Behaviour^ADM||1^Relaxed||||||F
OBX|211|TX|MhBHBEHC01^Behaviour other^ADM||test||||||F
OBX|212|CE|MhBHCFAC01^Behaviour contributing factors^ADM||01^Sleep deprivation||||||F
OBX|213|TX|MhBHCFCC01^Behaviour contributing factors other^ADM||test||||||F
OBX|214|CE|MhBHEYEC01^Eye contact^ADM||1^Adequate||||||F
OBX|215|TX|MhBHMGTD00^Behaviour management interventions details^ADM||test||||||F
OBX|216|CE|MhBHMGTI01^Behaviour management interventions^ADM||01^Decr environmental stim||||||F
OBX|217|TX|MhBHMGTO00^Behaviour management interventions other^ADM||test||||||F
OBX|218|CE|MhBHPMAO00^Psychomotor activity^ADM||1^No problem identified||||||F
OBX|219|TX|MhBHPMAO01^Psychomotor activity other^ADM||test||||||F
OBX|220|CE|MhBOWAID00^Bowel protocol/aids given^ADM||02^Meds per bowel protocol||||||F
OBX|221|TX|MhCAREAC00^Other care activity comments^ADM||test19||||||F
OBX|222|CE|MhCOATTS01^Attention/Concentration^ADM||1^Good||||||F
OBX|223|CE|MhCOINSI01^Insight^ADM||2^Partial||||||F
OBX|224|CE|MhCOJUDG01^Judgement^ADM||2^Limited||||||F
OBX|225|CE|MhCOMEMO01^Memory^ADM||1^Immediate/Recall intact||||||F
OBX|226|CE|MhCOORIE01^Oriented to^ADM||2^Person||||||F
OBX|227|TX|MhECTCOM00^Other ECT comments^ADM||returned and had breakfast||||||F
OBX|228|TX|MhECTPRE00^Pre-ECT comments^ADM||test||||||F
OBX|229|TX|MhECTTXN00^ECT treatment number^ADM||3||||||F
OBX|230|TX|MhELIMAC00^Elimination comments^ADM||test15||||||F
OBX|231|TX|MhELIMBO00^Bowel concerns identified^ADM||N||||||F
OBX|232|TX|MhELIMTL00^Independent with toileting^ADM||Y||||||F
OBX|233|TX|MhELIMUC00^Urinary concerns identified^ADM||N||||||F
OBX|234|TX|MhESAFFE02^Affect other^ADM||test||||||F
OBX|235|CE|MhESAFFM04^Affect^ADM||1^Appropriate||||||F
OBX|236|TX|MhESMOOD03^Mood rate/level^ADM||3.0||||||F
OBX|237|TX|MhFALLRK00^Fall risk^ADM||Y||||||F
OBX|238|TX|MhGENCON00^General concerns identified^ADM||test3||||||F
OBX|239|TX|MhHOIDEA00^Homicidal ideation present^ADM||N||||||F
OBX|240|TX|MhLOBCO001^Level of observation comments^ADM||test||||||F
OBX|241|CE|MhLOBMT001^Level of observation maintained^ADM||1^Level 1||||||F
OBX|242|CE|MhLOBSA101^Current level of observation^ADM||1^Level 1||||||F
OBX|243|CE|MhMCSIAJ01^There have been family adjustments^ADM||1^Yes on a regular basis||||||F
OBX|244|CE|MhMCSIBH01^Some behaviour is upsetting^ADM||3^No||||||F
OBX|245|CE|MhMCSICG02^Caregiving is inconvenient^ADM||2^Yes sometimes||||||F
OBX|246|CE|MhMCSICH01^Upset they have changed from their former self^ADM||3^No||||||F
OBX|247|CE|MhMCSICN01^Caregiving is confining^ADM||2^Yes sometimes||||||F
OBX|248|CE|MhMCSIDT01^There have been other demands on my time^ADM||1^Yes on a regular basis||||||F
OBX|249|CE|MhMCSIEM01^There have been emotional adjustments^ADM||2^Yes sometimes||||||F
OBX|250|CE|MhMCSIFS01^Caregiving is a financial strain^ADM||1^Yes on a regular basis||||||F
OBX|251|CE|MhMCSIOV02^I feel completely overwhelmed^ADM||3^No||||||F
OBX|252|CE|MhMCSIPL01^There have been changes in personal plans^ADM||1^Yes on a regular basis||||||F
OBX|253|CE|MhMCSIPS01^Caregiving is a physical strain^ADM||2^Yes sometimes||||||F
OBX|254|CE|MhMCSISL01^My sleep is disturbed^ADM||3^No||||||F
OBX|255|TX|MhMCSITL02^Total score^ADM||12||||||F
OBX|256|CE|MhMCSIWO01^There have been work adjustments^ADM||3^No||||||F
OBX|257|CE|MhMEDIN012^Medical instability: Risk factors^ADM||01^No present concerns||||||F
OBX|258|CE|MhMSEAS015^Thought process^ADM||1^Organized||||||F
OBX|259|CE|MhMSEATT01^Attitude^ADM||1^Cooperative||||||F
OBX|260|CE|MhMSECOM00^Mental status assessment completed^ADM||02^Post-ECT||||||F
OBX|261|CE|MhNRESI001^Type(s) of non-restraint interventions used^ADM||01^Preventative strategies||||||F
OBX|262|TX|MhPAINPR01^Pain present^ADM||Y||||||F
OBX|263|TX|MhPATBE001^Behaviour observed^ADM||est||||||F
OBX|264|CE|MhPERDIS00^Perceptual disturbances^ADM||1^No problem identified||||||F
OBX|265|CE|MhREST0001^Reason for restraint use^ADM||1^Harm to self||||||F
OBX|266|TX|MhREST0008^Personal items/valuables removed and stored^ADM||Y||||||F
OBX|267|CE|MhRESTBP01^Body location physical restraint applied to^ADM||01^Left wrist||||||F
OBX|268|TX|MhRESTDC01^Restraint use discontinuation comments^ADM||test||||||F
OBX|269|TX|MhRESTE025^Other restraint use comments^ADM||test||||||F
OBX|270|TX|MhRESTE031^Team present during restraint use initiation^ADM||test||||||F
OBX|271|TX|MhRESTE032^Event details during restraint use initiation^ADM||test||||||F
OBX|272|TX|MhRESTEV01^Evaluation for continued restraint use assessed/reassessed^ADM||Y||||||F
OBX|273|CE|MhRESTPE01^Equipment physical restraint applied to^ADM||01^Stretcher||||||F
OBX|274|CE|MhRESTPT01^Type of physical restraint used^ADM||01^Magnetic lock and pin||||||F
OBX|275|TX|MhRESTSC01^Physical restraint monitoring/safety check tool in use^ADM||Y||||||F
OBX|276|CE|MhRESTUP01^Restraint use plan^ADM||01^Restraint continued||||||F
OBX|277|TX|MhRTUNIT00^Time patient returned to unit^ADM||1400||||||F
OBX|278|TX|MhSALLKP00^Saline lock present^ADM||N||||||F
OBX|279|TX|MhSECRIP01^Patient/Family consulted and Informed Consent obtained^ADM||Y||||||F
OBX|280|TX|MhSECRIP02^Interprofessional team members consulted^ADM||test||||||F
OBX|281|TX|MhSECRIP03^Consent for restraint use comments^ADM||est||||||F
OBX|282|TX|MhSFCARE00^Independent with personal care^ADM||Y||||||F
OBX|283|CE|MhSIPROT04^Protective factors^ADM||3^Ability to access help~4^Sense of responsibility||||||F
OBX|284|CE|MhSIRISK02^Suicide risk level/Degree of risk^ADM||1^No (forseeable) risk||||||F
OBX|285|CE|MhSNVUN022^Self neglect/Vulnerability: Risk factors^ADM||01^No present concerns||||||F
OBX|286|CE|MhSPAMOT01^Speech amount^ADM||5^Normal||||||F
OBX|287|CE|MhSPTONE05^Speech tone^ADM||1^Normal||||||F
OBX|288|CE|MhSPVOLU01^Speech volume^ADM||3^Soft||||||F
OBX|289|TX|MhSSACHE01^Signs and symptoms of headache/muscle soreness present^ADM||N||||||F
OBX|290|TX|MhSUIDEA00^Suicidal ideation present^ADM||N||||||F
OBX|291|CE|MhSUSH0022^Suicide/Self harm: Risk factors^ADM||5^Hx of suicide attempts~13^Lack of social supports||||||F
OBX|292|CE|MhTPCONT02^Thought content^ADM||1^No problem identified||||||F
OBX|293|TX|MhVERDIR00^Able to follow verbal direction^ADM||Y||||||F
OBX|294|CE|MoAIDUSE00^Aid used for independent ambulation^ADM||1^Standard walker||||||F
OBX|295|CE|MoAMASTN03^Assistance required for ambulation^ADM||3^1 person assist||||||F
OBX|296|CE|MoAMBABI00^Ambulation ability^ADM||1^Independent||||||F
OBX|297|TX|MoAMBIND00^Independent with ambulation^ADM||Y||||||F
OBX|298|TX|MoAMCMTS00^Ambulation comment^ADM||test8||||||F
OBX|299|CE|MoAMMBAD00^Mobility aid used for ambulation^ADM||1^Standard walker||||||F
OBX|300|CE|MoAMRMWD00^Ambulation^ADM||1^Within room||||||F
OBX|301|CE|MoAOTAO000^Ambulation outcome^ADM||3^Patient refused session||||||F
OBX|302|TX|MoAOTAOC00^Ambulation outcome comments^ADM||stating 10/10 pain||||||F
OBX|303|CE|MoAOTBO000^Bed exercises outcome^ADM||1^Completed as assigned||||||F
OBX|304|CE|MoAOTEO000^Exercise class outcome^ADM||1^Completed as assigned||||||F
OBX|305|TX|MoAOTOHC00^Other task outcome comments^ADM||GRASP completed in part missing last 5||||||F
OBX|306|CE|MoAOTOHO00^Other tasks outcome^ADM||2^Completed in part||||||F
OBX|307|CE|MoAOTTPO00^Therapy program outcome^ADM||1^Completed as assigned||||||F
OBX|308|CE|MoAOTTR002^Reviewed assignment of task^ADM||1^Assignment of task~2^Clinical history~3^Mobility recommendations~4^Infection control~5^Weight bearing order||||||F
OBX|309|CE|MoAOTUBO00^Upper body dressing outcome^ADM||1^Completed as assigned||||||F
OBX|310|CE|MoAOTWO000^Wheelchair practice outcome^ADM||1^Completed as assigned||||||F
OBX|311|CE|MoCFSCOR01^Clinical Frailty Scale score^ADM||5^5-Mildly frail||||||F
OBX|312|TX|MoHRSAMB00^Number of hours postpartum at first ambulation^ADM||2.00||||||F
OBX|313|TX|MoWBSM0000^Weight bearing order maintained^ADM||Y||||||F
OBX|314|TX|NeCIDG0000^CIWA-Ar dose given^ADM||2.00||||||F
OBX|315|CE|NeCIMA0000^CIWA-Ar medication administered^ADM||1^Diazepam||||||F
OBX|316|TX|NeCIRE0002^CIWA-Ar Alcohol Withdrawal Score^ADM||27||||||F
OBX|317|CE|NeCIWA1000^Headache, fullness in head^ADM||6^3||||||F
OBX|318|CE|NeCIWAA100^Nausea and vomiting^ADM||5^1||||||F
OBX|319|CE|NeCIWAA200^Tremor^ADM||2^2||||||F
OBX|320|CE|NeCIWAA300^Paroxysmal sweats^ADM||6^3||||||F
OBX|321|CE|NeCIWAA400^Anxiety^ADM||3^4||||||F
OBX|322|CE|NeCIWAA500^Agitation^ADM||7^5||||||F
OBX|323|CE|NeCIWAA600^Orientation^ADM||5^4||||||F
OBX|324|CE|NeCIWAA700^Tactile disturbances^ADM||2^2||||||F
OBX|325|CE|NeCIWAA800^Auditory disturbances^ADM||5^1||||||F
OBX|326|CE|NeCIWAA900^Visual disturbances^ADM||2^2||||||F
OBX|327|TX|NeCIWAOT00^Other CIWA-Ar comments^ADM||test||||||F
OBX|328|TX|NeCLDRSC01^Clock drawing test score^ADM||3||||||F
OBX|329|TX|NeCLGEOB00^Clock drawing test general observations^ADM||testing general observations||||||F
OBX|330|TX|NeCLSURE00^Clock drawing test summary of results^ADM||results summary||||||F
OBX|331|TX|NeCOBLEE00^Concerns re: bleeding^ADM||N||||||F
OBX|332|TX|NeCOCOM000^Cognition and orientation comments^ADM||A\T\Ox2 person and place||||||F
OBX|333|TX|NeGLBLGU00^Glucometer blood glucose^ADM||6.0||||||F
OBX|334|CE|NeLECONS00^Level of consciousness^ADM||1^Alert||||||F
OBX|335|CE|NeORIENT01^Oriented to^ADM||1^All domains||||||F
OBX|336|CE|NePOSC0000^POSS score^ADM||2^2 - Slightly drowsy||||||F
OBX|337|CE|NmHIVSCR00^HIV screening^ADM||2^Negative||||||F
OBX|338|TX|NmPRECAR00^Prenatal care^ADM||Y||||||F
OBX|339|TX|Nu00000200^Oral nutrition amount of meal consumed comments^ADM||test11||||||F
OBX|340|TX|Nu00014500^Short acting insulin administration time^ADM||1526||||||F
OBX|341|TX|Nu00014600^Intermediate acting insulin administration time^ADM||1527||||||F
OBX|342|TX|Nu00014700^Intermediate acting insulin type^ADM||IAT||||||F
OBX|343|TX|Nu00014801^Intermediate acting insulin dose^ADM||2.00||||||F
OBX|344|TX|Nu00014900^Long acting insulin administration time^ADM||1527||||||F
OBX|345|CE|Nu00016400^Insulin injection site^ADM||1^Right upper arm||||||F
OBX|346|CE|NuBRAMCO02^Breakfast amount consumed^ADM||01^0%||||||F
OBX|347|CE|NuDIAMCO02^Dinner amount consumed^ADM||01^0%||||||F
OBX|348|TX|NuEN000200^Enteral nutrition hold date^ADM||20181105||||||F
OBX|349|TX|NuEN000300^Enteral nutrition hold time^ADM||1030||||||F
OBX|350|TX|NuEN000400^Enteral nutrition resume date^ADM||20181105||||||F
OBX|351|TX|NuEN000500^Enteral nutrition resume time^ADM||1100||||||F
OBX|352|CE|NuENDELI00^Enteral nutrition delivery schedule^ADM||4^Intermittent||||||F
OBX|353|TX|NuENFLFR00^Feeding tube flush frequency^ADM||QID||||||F
OBX|354|CE|NuENFLPO03^Feeding tube flush purpose^ADM||2^Tube patency||||||F
OBX|355|CE|NuENFLUS01^Feeding tube flush type^ADM||1^Water||||||F
OBX|356|TX|NuENSOLU02^Enteral nutrition formula or solution^ADM||isosource||||||F
OBX|357|TX|NuIATIME00^Insulin administration time^ADM||1530||||||F
OBX|358|TX|NuIDOSLA01^Long acting insulin dose^ADM||1.25||||||F
OBX|359|TX|NuIDOSSA01^Short acting insulin dose^ADM||3.00||||||F
OBX|360|TX|NuIEFTFL00^Intake - enteral feeding tube flush^ADM||6.00||||||F
OBX|361|CE|NuIISITE00^Insulin injection site^ADM||1^Upper arm||||||F
OBX|362|TX|NuIOAMOU01^Intake, Other Amount^ADM||250.00||||||F
OBX|363|TX|NuITYPLA00^Long acting insulin type^ADM||LAT||||||F
OBX|364|TX|NuITYPSA00^Short acting insulin type^ADM||SAT||||||F
OBX|365|CE|NuLUAMCO02^Lunch amount consumed^ADM||01^0%||||||F
OBX|366|TX|NuNICUF113^Prepared Amount:  PDHM^ADM||30.0||||||F
OBX|367|TX|NuNICUF123^Prepared Amount:  UDHM^ADM||40.0||||||F
OBX|368|TX|NuNICUF133^Prepared Amount:  Breast Milk Substitute^ADM||45.0||||||F
OBX|369|TX|NuNICUF180^Trophic feed amount^ADM||5.0||||||F
OBX|370|TX|NuNICUF200^Duration of bottle feed^ADM||15||||||F
OBX|371|CE|NuNICUF210^Alternate feeding method^ADM||1^Supplemental nrsg system||||||F
OBX|372|CE|NuNICUF250^Breastfeeding observations^ADM||3^Strong latch~4^Audible swallow||||||F
OBX|373|CE|NuNICUF260^Breastfeeding assistance^ADM||2^Minimal assistance||||||F
OBX|374|CE|NuNICUF270^Bottle feeding observations^ADM||3^Strong suck||||||F
OBX|375|CE|NuNICUF282^Nipple type used^ADM||2^Slow flow nipple||||||F
OBX|376|CE|NuNICUF291^Trophic feeding content^ADM||1^Mother's milk||||||F
OBX|377|TX|NuNICUF300^Intake, Tube Feeding Amount^ADM||15.0||||||F
OBX|378|CE|NuNICUF310^Parental feeding goals^ADM||2^Mixed feeding||||||F
OBX|379|TX|NuNICUF330^Breast milk double checked by^ADM||John Doe, RN||||||F
OBX|380|TX|NuNICUF351^Intake, Breastfeeding Amount^ADM||15.0||||||F
OBX|381|TX|NuNICUF360^Nipple shield in use^ADM||N||||||F
OBX|382|TX|NuNICUF370^Intake, Oral Amount^ADM||17.0||||||F
OBX|383|TX|NuNICUF391^Current feeding plan^ADM||EBM 46 mL Q3H bottle with NG top up||||||F
OBX|384|TX|NuNICUF451^Pasteurized human donor milk batch number^ADM||X5483||||||F
OBX|385|TX|NuNICUF460^Tube feeding duration^ADM||90 minutes||||||F
OBX|386|TX|NuNICUF490^Tube feed current rate^ADM||5.0||||||F
OBX|387|TX|NuNICUFE30^Patient NPO^ADM||N||||||F
OBX|388|TX|NuNICUFE92^Prepared Amount:  Mother's EBM^ADM||25.0||||||F
OBX|389|TX|NuNPOPAT00^Patient currently NPO^ADM||Y||||||F
OBX|390|TX|NuONSOOT00^Oral nutrition food source other^ADM||test10||||||F
OBX|391|CE|NuONSOUR00^Oral nutrition food source^ADM||1^Hospital~2^Family or friends||||||F
OBX|392|TX|NuOSTOOL00^Output - stool^ADM||500.00||||||F
OBX|393|TX|NuOURINE00^Output - urine^ADM||250.00||||||F
OBX|394|TX|NuOUSMIX00^Output - urine/stool mix^ADM||750.00||||||F
OBX|395|CE|NuPEDFEE70^Hold reasons^ADM||2^Procedure||||||F
OBX|396|CE|NuSNAMCO02^Snack amount consumed^ADM||01^0%||||||F
OBX|397|CE|OEISO^Infection Control:^ADM||CP^Contact Plus||||||F
OBX|398|TX|OhEDIT0000^Reason for edit^ADM||needed to complete||||||F
OBX|399|CE|OhGS000100^Group B Streptococcus status^ADM||1^Negative||||||F
OBX|400|CE|OhHEPBST00^Hepatitis B status^ADM||1^Negative||||||F
OBX|401|TX|OhHSLPRE00^Herpes simplex lesions present^ADM||N||||||F
OBX|402|CE|OhIN000300^Information source^ADM||1^Patient||||||F
OBX|403|TX|OhINFSS000^Influenza signs or symptoms^ADM||N||||||F
OBX|404|TX|PaDBLEOL00^Double check^ADM||RNURSE||||||F
OBX|405|CE|PaFREQ0000^Pain frequency^ADM||3^Constant||||||F
OBX|406|CE|PaLOCBDS02^Location^ADM||20^Perineum||||||F
OBX|407|TX|PaPAGOAL02^Pain goal^ADM||2/10||||||F
OBX|408|CE|PaPAIASS00^Pain assessment^ADM||2^Pain reported||||||F
OBX|409|CE|PaPANVBA00^Pain non-verbal behaviours^ADM||3^Agitated~9^Moans||||||F
OBX|410|CE|PaPAQUAL01^Pain quality^ADM||4^Ache~5^Burning||||||F
OBX|411|CE|PaPARAMR00^Pain defined parameters^ADM||2^Significant findings||||||F
OBX|412|CE|PaPASCL000^Pain scale used^ADM||1^Numeric||||||F
OBX|413|CE|PaPASCLE01^Pain scale used^ADM||1^Numeric||||||F
OBX|414|TX|PaPASCRE01^Pain score^ADM||8.00||||||F
OBX|415|TX|PaPATEXP00^Patient experiencing pain^ADM||N||||||F
OBX|416|CE|PaPATYPE00^Pain type of onset^ADM||1^Gradual||||||F
OBX|417|CE|PaPNMGTT00^Pain management techniques^ADM||1^Medication~2^Ice pack||||||F
OBX|418|TX|PhDBLCHK00^Double check by^ADM||Bob Smith, RN||||||F
OBX|419|TX|PhLIDOBD00^Lidocaine bolus dose^ADM||125.00||||||F
OBX|420|TX|PhLIDODI00^Lidocaine infusion initiation date^ADM||20200106||||||F
OBX|421|CE|PhLIDODU00^Lidocaine ordered duration^ADM||1^12 hours||||||F
OBX|422|TX|PhLIDOID01^Lidocaine infusion dose^ADM||10.00||||||F
OBX|423|TX|PhLIDOIR00^Lidocaine infusion rate^ADM||20.00||||||F
OBX|424|TX|PhLIDOIT00^Lidocaine infusion initiation time^ADM||1300||||||F
OBX|425|TX|PhLIDOLD00^Lidocaine loading dose initiation date^ADM||20200106||||||F
OBX|426|TX|PhLIDOLT00^Lidocaine loading dose initiation time^ADM||1000||||||F
OBX|427|TX|PhLIDOSC01^Lidocaine scheduled end time^ADM||0100||||||F
OBX|428|CE|PhLIDOSE03^Lidocaine infusion side effects^ADM||1^None||||||F
OBX|429|TX|PhLIDOTT03^Lidocaine infused total time^ADM|| hours,  minutes||||||F
OBX|430|TX|PhLIDSED00^Lidocaine scheduled end date^ADM||20200107||||||F
OBX|431|TX|PsBO000903^Skin to skin contact performed^ADM||Y||||||F
OBX|432|TX|PsFAMCOP00^Family exhibits positive coping skills^ADM||Y||||||F
OBX|433|TX|PsFBCUES01^Effective responses to feeding and behaviour cues^ADM||Y||||||F
OBX|434|CE|PsGENCII00^Issues identified^ADM||1^Multiple encounters~9^Sensory deficits||||||F
OBX|435|TX|PsMAT00000^Ministry of Children and Family Development alert^ADM||N||||||F
OBX|436|TX|PsMAT00100^Appropriate bonding and attachment^ADM||Y||||||F
OBX|437|TX|PsMATSUP00^Maternal supports present^ADM||Y||||||F
OBX|438|CE|RePEWSSO00^Supplemental oxygen delivered^ADM||5^Room air||||||F
OBX|439|TX|RpBLDL0100^Output, Blood Loss Amount^ADM||500.30||||||F
OBX|440|TX|RpBLDL0200^Postpartum hemorrhage comments^ADM||test12||||||F
OBX|441|CE|RpBLDL0300^Estimated blood loss^ADM||1^less than 500mL||||||F
OBX|442|TX|RpBR000100^Breast assessment colostrum present^ADM||Y||||||F
OBX|443|CE|RpBREAST00^Breast defined parameters^ADM||2^Significant findings||||||F
OBX|444|CE|RpBREAST10^Nipple defined parameters^ADM||2^Significant findings||||||F
OBX|445|CE|RpBRHXSX00^Breast history/surgery^ADM||1^None||||||F
OBX|446|TX|RpBRMPRE00^Breast milk present^ADM||Y||||||F
OBX|447|CE|RpDE000100^Delivery type^ADM||1^SVD||||||F
OBX|448|TX|RpDE000400^Delivery date^ADM||20180820||||||F
OBX|449|TX|RpDE000500^Delivery time^ADM||1440||||||F
OBX|450|CE|RpENGCOM00^Engorgement comfort measures^ADM||2^Warm compress||||||F
OBX|451|CE|RpFU000100^Fundus location^ADM||1^Central||||||F
OBX|452|CE|RpFU000301^Fundus tone^ADM||2^Firm with massage||||||F
OBX|453|CE|RpFUNHEI00^Fundal height^ADM||4^1 cm below umbilicus||||||F
OBX|454|TX|RpLABDEL10^Previous breastfeeding experience^ADM||Y||||||F
OBX|455|TX|RpLBRDL000^Newborn gestational age in weeks^ADM||36||||||F
OBX|456|TX|RpLBRDL010^Newborn gestational age in days^ADM||5||||||F
OBX|457|CE|RpMAT00000^Location Modifier^ADM||1^Right||||||F
OBX|458|CE|RpMAT00100^Breast condition^ADM||3^Engorged||||||F
OBX|459|CE|RpMAT00300^Breast evidence of engorgement^ADM||3^Reddened area||||||F
OBX|460|CE|RpMAT00500^Nipple description^ADM||3^Flat||||||F
OBX|461|CE|RpMAT00600^Nipple surface^ADM||2^Bruised||||||F
OBX|462|TX|RpNIPCRE00^Nipple cream used^ADM||Y||||||F
OBX|463|CE|RpNIPST002^Breast milk expression method^ADM||3^Pumping||||||F
OBX|464|TX|RpPER00000^Perineum comfort measures used other^ADM||test4||||||F
OBX|465|CE|RpPERAPP00^Perineum appearance^ADM||2^Laceration unrepaired||||||F
OBX|466|CE|RpPERCM001^Perineum comfort measures used^ADM||1^Ice pack~2^Tea pads||||||F
OBX|467|TX|RpPERCOM00^Perineum comments^ADM||test5||||||F
OBX|468|CE|RpPERCON01^Perineum condition^ADM||2^Tenderness~5^Bruising||||||F
OBX|469|TX|RpPERCONOH^Perineum condition other^ADM||test3||||||F
OBX|470|CE|RpPERLAC00^Perineum laceration degree^ADM||1^1 degree||||||F
OBX|471|TX|RpPR000200^Pregnancy history gravida^ADM||0||||||F
OBX|472|TX|RpPR000300^Pregnancy history term^ADM||1||||||F
OBX|473|TX|RpPR000400^Pregnancy history preterm^ADM||0||||||F
OBX|474|TX|RpPR000500^Pregnancy history abortion^ADM||0||||||F
OBX|475|TX|RpPR000600^Pregnancy history living children^ADM||1||||||F
OBX|476|CE|RpRPASSE00^Lochia amount^ADM||2^Scant||||||F
OBX|477|CE|RpRPASSE11^Lochia description^ADM||2^Serosa||||||F
OBX|478|TX|RpRPASSE20^Lochia description other^ADM||test||||||F
OBX|479|TX|RpRPASSE30^Clots present^ADM||Y||||||F
OBX|480|CE|RpRPASSE40^Lochia odour^ADM||1^None||||||F
OBX|481|TX|RpRPASSE50^Lochia comments^ADM||test2||||||F
OBX|482|TX|RpRPASSE60^Abdominal incision antiseptic cleansing solution^ADM||test6||||||F
OBX|483|TX|RpSYSCOM00^Other reproductive system comments^ADM||test13||||||F
OBX|484|TX|SpBASFAL00^Injuries sustained from fall^ADM||pt's dad states pt 'collapsed' on way to BR.  cut lip, pressure applied,~bruise noted to left forehead||||||F
OBX|485|TX|SpCONRA000^Patient consented to RA session^ADM||Y||||||F
OBX|486|TX|SpDP000000^Discharge planned within 24 hours^ADM||N||||||F
OBX|487|TX|SpERPCHA00^Changed into hospital attire^ADM||Y||||||F
OBX|488|TX|SpERPIRS00^Informed of reason for restraint use and process^ADM||Y||||||F
OBX|489|TX|SpFALFIR00^Fall first responder^ADM||Bob, pt's dad||||||F
OBX|490|TX|SpFALWIT00^Fall witnessed^ADM||Y||||||F
OBX|491|TX|SpFUHH0000^Follow-up initiated for unwitnessed fall and/or head injury^ADM||Y||||||F
OBX|492|TX|SpHENEIN01^Concerns re: possible head and/or neck injury^ADM||Y||||||F
OBX|493|TX|SpINJFAL00^Other injuries sustained in fall^ADM||N||||||F
OBX|494|CE|SpIPRATI03^Isolation precautions rationale suspected/confirmed ED^ADM||16^Norovirus||||||F
OBX|495|CE|SpLRRAOL00^Location behaviour occurred^ADM||2^Bedside||||||F
OBX|496|TX|SpNICUFA60^Caregiver/Family notified^ADM||N||||||F
OBX|497|TX|SpORNEIN00^Concerns re: orthopedic/neurovascular injury^ADM||N||||||F
OBX|498|TX|SpOSPATT01^Observed sleep pattern^ADM||test16||||||F
OBX|499|TX|SpPER00000^Appropriate family functioning^ADM||Y||||||F
OBX|500|TX|SpPFSH0000^Post fall safety huddle completed^ADM||Y||||||F
OBX|501|TX|SpPOVINI00^Follow-up initiated for possible vascular injury^ADM||N||||||F
OBX|502|TX|SpREPSLE00^Reported sleep pattern^ADM||test17||||||F
OBX|503|CE|SpRU000100^Rubella status immunity^ADM||1^Immune||||||F
OBX|504|TX|SpSLEAID00^Sleep aid PRN given^ADM||Y||||||F
OBX|505|TX|SpTIMEFD00^Time fall discovered/occurred^ADM||0937||||||F
OBX|506|TX|TeEDINTR00^Interpreter utilized^ADM||N||||||F
OBX|507|TX|TePFEDU000^Post fall education provided^ADM||Y||||||F
OBX|508|TX|VsBPDIAA00^Blood pressure diastolic^ADM||90||||||F
OBX|509|TX|VsBPDIAO01^Blood pressure diastolic^ADM||80||||||F
OBX|510|TX|VsBPSYSA00^Blood pressure systolic^ADM||120||||||F
OBX|511|TX|VsBPSYSO01^Blood pressure systolic^ADM||120||||||F
OBX|512|TX|VsHRADLT01^Heart rate^ADM||80||||||F
OBX|513|TX|VsPEW00000^Respiratory rate score^ADM||1||||||F
OBX|514|TX|VsPEW00100^Pulse rate PEWS score^ADM||3||||||F
OBX|515|CE|VsPEWBEM00^Bronchodilator every 15 minutes^ADM||2^No||||||F
OBX|516|CE|VsPEWCRT00^Capillary refill time^ADM||1^1-2 seconds||||||F
OBX|517|CE|VsPEWPVS00^Persistent vomiting following surgery^ADM||2^No||||||F
OBX|518|CE|VsPEWSBE00^Behaviour^ADM||1^Playing/Appropriate||||||F
OBX|519|TX|VsPEWSCR00^Total PEWS score^ADM||4||||||F
OBX|520|TX|VsPEWSFC00^PEWS score for cardiovascular^ADM||3||||||F
OBX|521|TX|VsPEWSPR00^Pulse rate^ADM||100||||||F
OBX|522|CE|VsPEWSRD00^Respiratory distress^ADM||1^None||||||F
OBX|523|TX|VsPEWSRR00^Respiratory rate^ADM||65||||||F
OBX|524|TX|VsPEWSSB00^PEWS score for behaviour^ADM||0||||||F
OBX|525|CE|VsPEWSSC00^Skin colour^ADM||1^Pink||||||F
OBX|526|TX|VsPEWSSR00^PEWS score for respiratory^ADM||1||||||F
OBX|527|TX|VsPOOSAD00^Pulse oximetry oxygen saturation^ADM||99||||||F
OBX|528|TX|VsRESPAD00^Respiration rate^ADM||14||||||F
OBX|529|TX|VsRESPAD03^Respiratory rate^ADM||13||||||F
OBX|530|TX|VsTPTEMPO2^Temperature^ADM||36.3||||||F
OBX|531|TX|VsWT000101^Current Weight^ADM||60.000||||||F
OBX|532|CE|VsWT000700^Weight measurement method^ADM||1^Standing scale||||||F
OBX|533|TX|VsWTGRAM00^Weight (Calculated Grams)^ADM||60000.000||||||F
ZFD|SEUSST^SEUSS *TEST^THEODORE^*TEST* G^^^^12^DOC|123 ROAD^^SURREY^BC^V2V 0A0|||SEUSST^SEUSS *TEST^THEODORE^*TEST* G^^^^12^DOC|SEUSST^SEUSS *TEST^THEODORE^*TEST* G^^^^12^DOC|
ZFH|LUMED|||||||||NSCTL

